Bell Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.7M | Sell |
2,255
-25
| -1% | -$25.5K | 0.1% | 71 |
|
|
2026
Q1 | $2.1M | Sell |
2,280
-28
| -1% | -$28.4K | 0.09% | 76 |
|
|
2025
Q4 | $2.48M | Buy |
2,308
+542
| +31% | +$518K | 0.11% | 64 |
|
|
2025
Q3 | $1.35M | Buy |
1,766
+170
| +11% | +$127K | 0.06% | 92 |
|
|
2025
Q2 | $1.24M | Hold |
1,596
| – | – | 0.06% | 91 |
|
|
2025
Q1 | $1.32M | Buy |
1,596
+99
| +7% | +$82.4K | 0.07% | 84 |
|
|
2024
Q4 | $1.16M | Buy |
1,497
+5
| +0.3% | +$4.14K | 0.09% | 90 |
|
|
2024
Q3 | $1.32M | Buy |
1,492
+23
| +2% | +$20.7K | 0.16% | 82 |
|
|
2024
Q2 | $1.33M | Hold |
1,469
| – | – | 0.11% | 75 |
|
|
2024
Q1 | $1.14M | Hold |
1,469
| – | – | 0.1% | 88 |
|
|
2023
Q4 | $856K | Sell |
1,469
-1,228
| -46% | -$717K | 0.08% | 99 |
|
|
2023
Q3 | $1.45M | Buy |
2,697
+283
| +12% | +$146K | 0.16% | 74 |
|
|
2023
Q2 | $1.13M | Buy |
2,414
+403
| +20% | +$169K | 0.12% | 88 |
|
|
2023
Q1 | $691K | Buy |
2,011
+321
| +19% | +$108K | 0.07% | 116 |
|
|
2022
Q4 | $618K | Buy |
1,690
+1
| +0.1% | +$355 | 0.07% | 121 |
|
|
2022
Q3 | $546K | Sell |
1,689
-27
| -2% | -$8.55K | 0.07% | 119 |
|
|
2022
Q2 | $556K | Buy |
1,716
+254
| +17% | +$76.2K | 0.07% | 125 |
|
|
2022
Q1 | $419K | Hold |
1,462
| – | – | 0.05% | 135 |
|
|
2021
Q4 | $404K | Hold |
1,462
| – | – | 0.05% | 140 |
|
|
2021
Q3 | $338K | Hold |
1,462
| – | – | 0.04% | 138 |
|
|
2021
Q2 | $336K | Hold |
1,462
| – | – | 0.04% | 141 |
|
|
2021
Q1 | $273K | Hold |
1,462
| – | – | 0.04% | 147 |
|
|
2020
Q4 | $247K | Buy |
+1,462
| New | +$218K | 0.04% | 150 |
|
|
2016
Q1 | – | Sell |
-3,734
| Closed | -$315K | – | 125 |
|
|
2015
Q4 | $315K | Sell |
3,734
-8,608
| -70% | -$714K | 0.23% | 85 |
|
|
2015
Q3 | $1.03M | Sell |
12,342
-3,266
| -21% | -$276K | 0.82% | 37 |
|
|
2015
Q2 | $1.3M | Sell |
15,608
-1,094
| -7% | -$83.4K | 0.97% | 27 |
|
|
2015
Q1 | $1.21M | Buy |
16,702
+82
| +0.5% | +$5.84K | 0.85% | 31 |
|
|
2014
Q4 | $1.15M | Sell |
16,620
-378
| -2% | -$25.5K | 0.79% | 31 |
|
|
2014
Q3 | $1.1M | Buy |
16,998
+577
| +4% | +$36.5K | 0.79% | 25 |
|
|
2014
Q2 | $1.02M | Buy |
16,421
+488
| +3% | +$29.1K | 0.72% | 35 |
|
|
2014
Q1 | $938K | Sell |
15,933
-2,248
| -12% | -$125K | 0.63% | 48 |
|
|
2013
Q4 | $927K | Sell |
18,181
-2,144
| -11% | -$107K | 0.48% | 77 |
|
|
2013
Q3 | $1.02M | Sell |
20,325
-220
| -1% | -$11.5K | 0.36% | 119 |
|
|
2013
Q2 | $1.01M | Buy |
+20,545
| New | +$1.12M | 0.35% | 122 |
|
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Bell Bank's LLY Position: Q2 2026 in Review
Bell Bank reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2026, selling an estimated $25.5K and leaving 2,255 shares worth $2.7M. The position accounts for 0.1% of the portfolio, ranked #71.
Bell Bank first reported a position in LLY in Q2 2013 and has held it in 34 quarters since. 900 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bell Bank held 2,255 shares of Eli Lilly worth $2.7M as of Q2 2026.
- Bell Bank sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
- Eli Lilly made up 0.1% of Bell Bank's portfolio in Q2 2026, its #71 holding.
- Bell Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 34 quarters since.
- 900 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.